Skip to main content
Year archive

AVECHO BIOTECHNOLOGY LIMITED — 2021 filings

All 36 regulatory filings released by AVECHO BIOTECHNOLOGY LIMITED (AVE) in 2021, sourced directly from the official regulator.

36 Filings
2021 Period
2021 filings (36)
Filing Released Lang
AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis 3 pages 222.5KB
Capital/Financing Update
2021-12-19 English
Positive results from Avecho's Phase I trial of CBD soft-gel 3 pages 118.0KB
Regulatory Filings
2021-12-07 English
September 2021 Quarterly Activities Report & Appendix 4C 8 pages 626.6KB
Interim / Quarterly Report
2021-10-28 English
Topical CBD pain study with Lambert Initiative approved 3 pages 119.5KB
Regulatory Filings
2021-10-20 English
Dosing begins in Phase I PK trial testing CBD soft-gel 2 pages 68.0KB
Regulatory Filings
2021-10-03 English
Phase I clinical trial testing CBD product-enrolment begins 3 pages 72.0KB
Regulatory Filings
2021-09-14 English
Notification of cessation of securities - AVE 4 pages 24.2KB
Share Issue/Capital Change
2021-09-09 English
Change of Director's Interest Notice 3 pages 232.7KB
Director's Dealing
2021-09-09 English
Appendix 4D and Half-year Financial Report 25 pages 863.5KB
Interim / Quarterly Report
2021-08-23 English
June 2021 Quarterly Activities Report & Appendix 4C 8 pages 347.0KB
Interim / Quarterly Report
2021-07-26 English
Section 708A Cleansing Statement 1 page 53.3KB
Share Issue/Capital Change
2021-06-30 English
Application for quotation of securities - AVE 6 pages 27.9KB
Share Issue/Capital Change
2021-06-30 English
Avecho to Present New CBD Data at GCI Virtual Summit 20 pages 1.7MB
Investor Presentation
2021-06-07 English
AB Vista to explore new TPM applications for Animal Health 2 pages 97.7KB
Capital/Financing Update
2021-05-30 English
Chair's Address and CEO Presentation 23 pages 713.1KB
AGM Information
2021-05-30 English
2021 Annual General Meeting Results 2 pages 73.4KB
Declaration of Voting Results & Voting Rights Announcements
2021-05-30 English
Final Director's Interest Notice 2 pages 214.8KB
Director's Dealing
2021-05-30 English
Appendix 3G 12 pages 233.9KB
Share Issue/Capital Change
2021-05-30 English
Change of Director's Interest Notice x3 9 pages 428.2KB
Director's Dealing
2021-05-30 English
TGA meeting for CBD soft-gel targeting insomnia 2 pages 97.7KB
Regulatory Filings
2021-05-25 English
Changes to AGM attendance protocols 5 pages 318.9KB
AGM Information
2021-05-25 English
Avecho completes pharmaceutical CBD soft-gel product 2 pages 193.1KB
Capital/Financing Update
2021-05-20 English
Resignation of Director & Withdrawal of AGM Resolution 1
Board/Management Information
2021-05-03 English
Notice of Annual General Meeting/Proxy Form 26 pages 670.7KB
AGM Information
2021-04-29 English
March 2021 Quarterly Activities Report & Appendix 4C 8 pages 347.7KB
Interim / Quarterly Report
2021-04-27 English
Avecho receives ethics approval for CBD human trial 2 pages 72.8KB
Regulatory Filings
2021-04-12 English
Annual Report - 31 December 2020 58 pages 800.7KB
Annual Report
2021-03-25 English
Appendix 4G and Corporate Governance Statement 25 pages 639.7KB
Regulatory Filings
2021-03-25 English
Appendix 4E - Preliminary Final Report 16 pages 400.5KB
Annual Report
2021-02-25 English
S708A Cleansing Notice and Appendix 2A 16 pages 395.1KB
Capital/Financing Update
2021-02-16 English
Appendix 2A - Options 17 pages 389.7KB
Capital/Financing Update
2021-02-16 English
Update - Proposed issue of Securities - AVE 8 pages 37.1KB
Capital/Financing Update
2021-02-15 English
AVE receives firm commitment to raise $5.06 via placement 3 pages 106.7KB
Capital/Financing Update
2021-02-09 English
Proposed issue of Securities - AVE 8 pages 37.2KB
Capital/Financing Update
2021-02-09 English
Trading Halt 3 pages 224.1KB
Capital/Financing Update
2021-02-07 English
December 2020 Quarterly Activities Report & Appendix 4C 7 pages 331.0KB
Interim / Quarterly Report
2021-01-28 English